What is NDC 62332-066?

62332-066 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 6 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine Tartrate?

36 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine Tartrate NDC 62332-066

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-066Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0066Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-066-10	6233200661062332006610	100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-066-10) / 10 CAPSULE in 1 BLISTER PACKMarketed from Jun 12, 2022
62332-066-30	6233200663062332006630	30 CAPSULE in 1 BOTTLE (62332-066-30)Marketed from Jun 12, 2022
62332-066-60	6233200666062332006660	60 CAPSULE in 1 BOTTLE (62332-066-60)Marketed from Jun 12, 2022
62332-066-71	6233200667162332006671	500 CAPSULE in 1 BOTTLE (62332-066-71)Marketed from Jun 12, 2022
62332-066-91	6233200669162332006691	1000 CAPSULE in 1 BOTTLE (62332-066-91)Marketed from Jun 12, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine Tartrate
Generic name (nonproprietary): rivastigmine tartrate
Active ingredients: Rivastigmine tartrate — 6 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091689
Marketing start: Jun 12, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 62332-066_0044f1d7-613c-4611-8481-13032c8cb390SPL ID 0044f1d7-613c-4611-8481-13032c8cb390SPL set ID 0044f1d7-613c-4611-8481-13032c8cb390RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0362332066308, 0362332063307
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332006610 followed by a unit qualifier and the quantity

Package 62332-0066-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 21, 2022.

Indications (excerpt from the label)

Rivastigmine tartrate capsules are an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) (1.1) Mild-to-moderate dementia associated with Parkinson’s disease (PD) (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62332-066

What is NDC 62332-066?: 62332-066 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 6 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine Tartrate.
What is the active ingredient?: Rivastigmine tartrate.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine Tartrate?: 36 other product NDCs are listed under this name. See all Rivastigmine Tartrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine Tartrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	American Health Packaging	60687-777	60687-0777-01
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063	62332-0063-1062332-0063-3062332-0063-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064	62332-0064-1062332-0064-3062332-0064-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065	62332-0065-1062332-0065-3062332-0065-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-011	72241-0011-0372241-0011-10
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-012	72241-0012-0372241-0012-10
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-013	72241-0013-0372241-0013-10
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-014	72241-0014-0372241-0014-10
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-900	62135-0900-60
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Chartwell RX, LLC	62135-901	62135-0901-60

All 37 Rivastigmine Tartrate NDCs

Other NDCs under ANDA 091689

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091689
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-063
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-064
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-065
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-066
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065